Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Polyphenon E in Superficial Bladder Cancer
NCT00088946Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- May 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib, green tea extract in bladder cancer, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started May 2004; status: completed.
02
Drugs
erlotinibgreen tea extract
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00088946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088946.